Holt-Oram Syndrome (HOS) is an autosomal dominant heart-hand syndrome caused by mutations in the TBX5 gene, a transcription factor capable of regulating hundreds of cardiac-specific genes through complex transcriptional networks. Here we show that, in zebrafish, modulation of a single miRNA is sufficient to rescue the morphogenetic defects generated by HOS. The analysis of miRNA-seq profiling revealed a decreased expression of miR-19a in Tbx5-depleted zebrafish embryos compared to the wild type. We revealed that the transcription of the miR-17-92 cluster, which harbors miR-19a, is induced by Tbx5 and that a defined dosage of miR-19a is essential for the correct development of the heart. Importantly, we highlighted that miR-19a replacement is able to rescue cardiac and pectoral fin defects and to increase the viability of HOS zebrafish embryos. We further observed that miR-19a replacement shifts the global gene expression profile of HOS-like zebrafish embryos towards the wild type condition, confirming the ability of miR-19a to rescue the Tbx5 phenotype. In conclusion our data demonstrate the importance of Tbx5/miR-19a regulatory circuit in heart development and provide a proof of principle that morphogenetic defects associated with HOS can be rescued by transient miRNA modulation.
Micro-RNAs (miRNAs) are evolutionarily-conserved noncoding RNAs approximately 22 nucleotides in length, which negatively regulate gene expression by translational repression or mRNA destabilization1,2. miRNAs have been implicated in numerous diseases3,4,5, including cancer6,7. The hypothesis that miRNA dysregulation is part of pathophysiological mechanisms underlying heart disease was first suggested by distinctive patterns of miRNA expression discovered in healthy and diseased mouse and human hearts (reviewed in8,9,10). miRNAs are now demonstrated to be actively involved in all aspects of cardiac remodeling, growth, proliferation, apoptosis, conductance and contractility. Thanks to their small size, their conserved and well characterized sequences and their ability to impact multiple mRNAs, which are often functionally related, miRNAs are able to modulate complex physiological phenotypes by fine-tuning entire functional networks and therefore are attractive potential targets for complex disease therapy11,12. Holt Oram syndrome (HOS) is an autosomal dominant disorder characterized by cardiac and upper limb abnormalities13. Mutations in T-box transcription factor 5 (TBX5) underlie this syndrome14,15. Even small perturbations in TBX5 expression have significant effects on the HOS phenotype and modify the expression of hundreds of genes as shown in a murine model of HOS16,17. Interestingly, although TBX5 has been exclusively characterized as transcriptional activator, about 30% of the genes identified by microarray as being differentially expressed in tbx5 haploinsufficient mice are upregulated. This result suggests that TBX5 exerts its action at least in part via indirect mechanisms, such as, for example, activation of repressors. Our working hypothesis is that miRNAs are critical negative effectors of TBX5: more specifically the peculiar ability of each miRNA to modulate many targets might contribute to expand the range of influence of TBX5 which is a pivotal gene in heart morphogenesis. In line with our hypothesis, we identified in zebrafish HOS model those miRNAs embedded in genes highly sensitive to Tbx5 dosage. In our previous work we showed that misregulation of miR-218, has a severe impact on heart development by affecting early heart morphogenesis18.
In the present work we first performed massive parallel sequencing of the small RNAs in zebrafish embryos depleted for Tbx5 by morpholino injection (Tbx5-morphants). Then, by analysing the RNA profiles, we identified the miRNAs downregulated in Tbx5-morphants. Among several differentially regulated miRNAs we selected miR-19a because of its capability to significantly rescue the cardiac and pectoral fin defects caused by Tbx5 depletion and because of its capability to improve the Tbx5 morphant viability when co-injected with the morpholino against Tbx5. By in situ hybridization, we demonstrated that the proper expression of crucial cardiac genes is restored by miR-19a replacement. Moreover we showed, by microarray analysis, that gene expression profile of Tbx5 morphants co-injected with miR-19a mimic clusters together with WT embryos. Furthermore several miR-19 targets, some of them with relevance for cardiovascular development, are found to be up regulated by Tbx5 depletion and restored to WT condition by miR-19a co-injection.
Tbx5a/b downregulation misregulates miRNA expression during zebrafish development
In order to identify miRNAs modulated by Tbx5, we simultaneously depleted both zebrafish Tbx5 paralogs19,20 by microinjecting embryos at 1-cell stage with morpholinos against Tbx5a and Tbx5b (MO-Tbx5a and MO-Tbx5b). These morpholinos have been already extensively used to functionally analyze Tbx5 paralogs19,20,21,22,23. About 70% of embryos injected with 1.5ng of MO-Tbx5a and 1.5 ng of MO-Tbx5b showed cardiac and fin defects (Fig. 1A,B). Embryos showing the typical heartstring (hts) phenotype associated to Tbx5 downregulation18,23 were manually selected at 48hpf under microscope (Fig. 1C). Total RNA was extracted from Tbx5 depleted embryos and from embryos microinjected with the same amount of control morpholino (MO-Ct)18. miRNA profiles were performed by next generation sequencing (NGS). We identified 8 miRNAs with a fold change (FC) higher than 1.8 and a number of reads per million (rpm) higher than 200 of which 6 down- and 2 up-regulated in hts morphants compared to MO-Ct injected embryos (Fig. 1D). Next, we focused our attention on miRNAs showing down-regulation as a consequence of Tbx5 depletion, which is the premise for a Tbx5 direct regulation. To test whether Tbx5 can induce the expression of these miRNAs, we over-expressed Tbx5 in two different mouse cardiac cell lines, P19CL624,25 and HL1 cells26. We showed by qRT-PCR analysis that the expression levels of miR-219, miR-190b, miR-19a, miR-7a and miR-7b significantly increase as a consequence of Tbx5 overexpression (Fig. 1E).
miR-19a is able to partially rescue heart/fin defects induced by MO-Tbx5
We investigated whether miR-219, miR-190b, miR-19a, 130a and miR-7b could be effectors of Tbx5 activity by testing whether the replacement of any of these miRNAs alone was able to rescue morphological defects induced by Tbx5 depletion18,23. The tool used for this screening is the transgenic Tg(Myl7:EGFP) zebrafish line showing EGFP-labelled cardiomyocytes. Since we had already shown that the penetrance of the MO-Tbx5b phenotype was lower compared to that of MO-Tbx5a18, we used only MO-Tbx5a for all the subsequent Tbx5 depletion experiments. Tg(Myl7:EGFP) embryos were injected with 1.5 ng of MO-Tbx5a and 0.25 ng of each miRNA mimic. Co-injection of miR-130a and miR-219 was ineffective while co-injection of miR-7b and miR-190b even worsened the Tbx5a morphant phenotypes (Fig. S1). On the other hand, doses below 1 ng of miR-19a mimic significantly reduce both cardiac and fin defects (Fig. 2A–C). Co-injection of MO-Tbx5a and non-coding miRNA mimic (miR-Ct) does not improve morphant phenotype (Fig. 2A–C).
We questioned whether the injection of miR-19a would improve the viability of Tbx5a morphants. Figure 2D shows that about 60% of the Tbx5a morphants co-injected with 0.25/0.5 ng of miR-Ct die around the 5th–6th day of development, when the oxygen exchange by passive diffusion is no longer sufficient to sustain aerobic metabolism and a functioning circulatory system becomes necessary for survival. Less than 20% of Tbx5a morphants were still viable at the 11th day of development. Conversely, more than 60% of morphants co-injected with 0.25 ng of miR-19a mimic were still alive at the 12th day of development (Fig. 2D). In line with the dose-dependency of the cardiac rescue data (Fig. 2A,B), co-injection of 0.5 ng of miR-19a was less effective than a lower dose in improving viability. To explain this result we speculate that a specific dosage of miR-19a would be necessary for proper heart development. Moreover, since miRNAs are fine tuned rheostatic regulators of biological processes by targeting many mRNAs, an excessive amount of a single miRNAs can lead to nonspecific repression of unrelated mRNAs, causing a worsening of the phenotype.
Replacement of miR-19a decreased the severity of cardiac defects produced by Tbx5b depletion too, although it did not increase the number of normal embryos (Fig. 2E). This result is in accordance with the partial redundancy of zebrafish Tbx5 paralog functions20.
Tbx5 modulation affects miR-17-92 cluster expression
We investigated whether Tbx5 directly regulates the expression of the miR-17-92 cluster, to which miR-19a belongs. The functional analysis of miR-17-92 members is complicated in vertebrates by the existence of several paralogs (Fig. 3A,B). However, there is only one miRNA-19a in fish as well as in human and rodent genomes27.
We scanned the genomic sequence upstream the microRNA cluster for Tbx5 consensus binding sites by TRANSFAC program28. A potential Tbx5 binding site was identified about 4500 bp upstream the putative transcription starting site of the miR-17-92 cluster. A sequence of 1600 bp spanning the Tbx5 binding site was cloned into the pGL3 promoter vector upstream of the luciferase reporter gene generating the pGL3-MIR construct. Transactivation assays were performed in HL1 cells transfected with different amounts of the Tbx5 expression vector and with pGL3-MIR in the presence of the pRL-TK vector as internal standard. Co-transfection of increasing doses of the pcDNA-Tbx5 resulted in a progressive increase of luciferase activity (Fig. 3C). Next, the transactivating ability of Tbx5 on the pGL3-MIR vector was compared with the capability of Tbx5 to transactivate the pGL3-Anf construct, which expresses luciferase under the control of the atrial natriuretic factor (Anf) promoter, an established direct target of Tbx516. A dose of 500 ng of the Tbx5 plasmid increases the activity of the pGL3-MIR and pGL3-Anf vectors by 2.5- and 5-folds respectively (Fig. 3D). In line with this data, transfection of a siRNA able to almost halve endogenous Tbx5 expression decreased the luciferase activity both in pGL3-MIR and pGL3-Anf (Fig. 3E).
Downregulation of the miR-17-92 cluster expression in Tbx5a morphants was further supported by whole mount In Situ Hybridization (ISH) experiments using a riboprobe for the primary transcript of the miR-17-92 cluster. We observed that more than 30% of the MO-Tbx5a injected embryos have reduced miR-17-92 expression in the cardiac district (Fig. 3F,G). Since the first consequence of Tbx5a depletion was the lack of pectoral fins, we could not evaluate miR-17-92 cluster modulation in this district. Embryos with reduced miR-17-92 hybridization signal always showed a strong phenotype and absence of pectoral fins. More specifically, pectoral fins, whose presence is suggestive of WT-like phenotype (20% of Tbx5a-morphants, Figs S1 and S2), never showed visible reduction of the ISH signal. Overall the data are consistent with miR-17-92 cluster modulation by Tbx5a also in the cardiac tissue of intact embryos.
These data led us to investigate if the replacement of other cluster members might rescue defects generated by Tbx5a depletion. To address this issue we assayed one member for each of the miRNA families which are present within the miR-17-92 cluster: miR-18a as member of miR-17 family, miR-19b for miR-19 family and miR-92a which belongs to miR-25 family. Data presented in Figure S2 demonstrate that none of the tested miRNA was able to reduce Tbx5a morphant defects.
miR-19a dysregulation affects zebrafish heart development
In order to investigate the effect of miR-19a dysregulation during early zebrafish development, we performed both gain- and loss-of-function experiments (GOF and LOF). Effects on heart morphogenesis and fin development were assessed by confocal analysis and bright-field microscopy, respectively. Increasing doses of miR-19a injected in Tg(Myl7:EGFP) embryos raised the frequency and severity of cardiac defects generated by Tbx5 depletion (Fig. 4A,B). In the less severe phenotype, only looping was affected (phenotype 1, Fig. 4A,B). Increasing the miRNA dose caused shrinkage of the ventricle, atrium bilobation and size reduction (phenotype 2, Fig. 4A,B). In the most severe phenotype, two small deformed hearts were detectable (phenotype 3, Fig. 4A,B). These hearts were still capable of contraction although with a very irregular rhythm. Strikingly, while injection of 2 ng of miR-Ct induced 20% of unlooped hearts, more than 50% of the miR-19a injected embryos presented cardiac defects of variable severity (Fig. 4B). The lowest dose of 0.13 ng, which was able to rescue the Tbx5a morphant phenotype (see Fig. 2A,B) did not cause any apparent cardiac defects (Fig. 4B). Fin lack or defects were never detected in miR-19a overexpressing embryos.
To evaluate the impact of miR-19a dysregulation on vascular integrity we also injected miR-19a mimic in Tg(flk1:EGFP;myl7:dsRED) transgenic line. Doses up to 1 ng of miR-19a mimic did not cause visible alterations in vascular structures (Fig. S3).
We performed LOF experiments using a specific morpholino to block the activity of miR-19a (MO-19a),with a non-coding morpholino as control (MO-Ct). Even a high dose (10 ng) of MO-19a did not affect embryo morphology (Fig. S4A,B) but it was able to rescue the morphological defects caused by miR-19a over-expression (Fig. S4C). We speculate that if miR-19a and Tbx5 are part of the same pathway, their LOF effects should be synergic. We injected Tg(Myl7:EGFP) embryos with 0.5 ng of MO-Tbx5a. This is a sub-phenotypic dose which generates less than 20% of mild cardiac defects and 10% of embryos without pectoral fins (compare Fig. 4C,D with Fig. 2A,C). Co-injection of the sub-phenotypic dose of MO-Tbx5a with 8 ng of MO-19a strongly increased the number of heart and pectoral fin defects suggesting a synergistic interaction between miR-19a and Tbx5a. Although miR-19a down-regulation alone was not sufficient to trigger the HOS phenotype in zebrafish, these data indicate that dysregulation of miR-19a level impacts heart development.
Genome-wide analysis of miR-19-induced rescue of Tbx5 morphants
To characterize the impact of miR-19a on molecular HOS phenotype, we focused on cardiac markers known to be deregulated in Tbx5a morphants/hts mutants. The Tbx5 target natriuretic peptide precursor A (Anf)29 and the sinus venosus (SV)- atrioventricular junction (AVJ) differentiation marker bmp430 have been previously shown to decrease their expression after Tbx5a depletion20,23. On the other hand, notch1b and versican a (Vcana) showed expanded expression compared to the WT in which the expression is restricted to the AVJ18,20,30. Vcana and bmp4 were also exploited as pectoral fin development markers because of their expression in the apical district and within the fin buds in case of bmp430,31. A high percentage of Tbx5a morphants co-injected with miR-19a mimic showed at 48hpf a recovered expression of the tested genes in both, cardiac and fin districts (Fig. 5). In addition, the recovery of the WT expression of the proepicardial markers Tbx18 and Wt1a indicates that the replacement of miR-19a is able to rescue the absence of proepicardial specification which is a feature of hts mutants32 (Fig. 5). We also analyzed the effect of miR-19a co-injection on valve morphology using the hemizygous Tg(tie-2:GFP) line, which allows to visualize the valve tissue. While alteration of Tbx5 expression causes an expansion of Tie2 expression in zebrafish embryos18, miR-19a replacement was able to restore the Tie2 expression in a high percentage of Tbx5a morphants (Fig. S5).
Furthermore, we explored the impact of miR-19a replacement at the global gene expression level, by comparing the microarray profiles of 24hpf zebrafish embryos co-injected with MO-Ct and miR-Ct (WT phenotype) to the profiles of MO-Tbx5a morphants co-injected with miR-Ct (hts phenotype), or with miR-19a (rescued phenotype). We first investigated the overall relationship between sample expression profiles using unsupervised hierarchical clustering analysis based on probe intensity signals. The dendrogram in Fig. 6A shows that, at probe-level, the genome-wide expression profile of rescued embryos is more similar to embryos with WT phenotype rather than to embryos presenting the hts phenotype. The reliability of the obtained cluster was confirmed by bootstrap analysis33 (see Fig. 6 legend and Supplementary Methods for details). In addition we employed principal component analysis (PCA) of probes log-transformed expression values to elucidate the main sources of variation. In the space of the first two principal components (PCs), which account for 61% (PC1) and 19% (PC2) of the total variance, the biological replicates of the three conditions were well-separated (Fig. 6B). PC1 discriminates hts from WT while rescued embryos are close to the WT on this axis (Fig. 6B). PC2 instead discriminates WT from morpholino-injected embryos independently from the miR-19a status.
Next, we measured the impact of Tbx5a depletion on the global gene expression patterns of embryos treated and untreated with miR-19a. We first identified genes that were differentially expressed (expression FC > 1.3, p < 0.05, FDR < 0.05) in MO-Tbx5a morphants compared to the MO-Ct. Then we intersected the identified genes with the set of differentially-expressed genes in embryos with rescued profiles compared to MO-Tbx5a morphants. We found 4963 genes, corresponding to 59,6% of the gene set altered in MO-Tbx5a embryos, that had significant changes in their expression in rescued embryos. Those genes and their log2 FC are shown in Fig. 6C. Interestingly, most of them (98,7%) resulted inversely modulated (see IIQ and IVQ in Fig. 6C) and their relative expression levels were highly anticorrelated (Pearson R2 = −0.9, p < 2.2e−16). Since those genes are both direct and indirect targets of miR-19a, in order to identify putative direct targets, we focused on transcripts down-regulated in miR-19a-coinjected Tbx5 morphants vs Tbx5 morphants (IIQ). Among the targets predicted by two algorithms (TargetScanFish and Pita) we found 293 transcripts (shown in red in Fig. 6C, Table S1) which were not only down-regulated in MO-Tbx5 + miR-19a embryos compared to MO-Tbx5 morphants, but also up-regulated in Tbx5 morphants vs control embryos. These transcripts represented an enriched subset (hypergeometric test p = 0.0001) compared to the background of predicted miR-19a targets for all expressed transcripts measured using the array. On the other hand, the number of predicted putative miR-19a targets in the IVQ (transcripts downregulated in MO-Tbx5 morphants and upregulated by the presence of miR-19a) is below the expected background frequency (hypergeometric test p < 2.2e−16). Furthermore, to evaluate the influence of modulated miR-19a targets on discriminating between hts and WT phenotypes, we selected from PCA the probes with the relative highest absolute loadings (10th percentile) along the PC1. We then selected 7834 probes, accounting for 49.1% of the total weight. These probes corresponded to 5552 unique genes and all the 293 predicted mir-19a targets were included in this list. The most significantly represented biological processes (p < 0.001) in this gene set, based on Gene Ontology (GO) classification34 were developmental process, multicellular organism and anatomical structure development (Fig. S6).
Q-RT-PCR analysis performed on 7 selected genes validated the array results (Fig. S7A). Among them the cardiac regulators MEF2Ca and Camk2n1a were tested by means of Dual Luciferase assays carried out on cloned 3’UTR. The ability of miR-19a to reduce the luciferase activity in a dose-dependent manner support its direct control on these crucial cardiac genes (Fig. S7B).
In summary, our data indicate that miR-19a acts as a Tbx5 negative effector regulating several aspects of cardiovascular development.
Despite substantial progress in the comprehension of main roles played by transcription factors in cardiac development, there are gaps in our understanding of the interconnections between cardiogenic transcription factors and their downstream effector genes. Tbx5 is a crucial player in heart development. A network of cardiac transcription factors has been suggested as responsible of the complex Tbx5-dependent regulation17. In this work, using zebrafish as HOS model system, we show that miR-19a has a crucial role in the Tbx5 regulatory network. We found that miR-19a is down-regulated in Tbx5 depleted zebrafish embryos and that Tbx5a modulation affects the expression of the miR-17-92 cluster, which hosts miR-19a. Importantly, we showed that modulating miR-19a levels partially rescues cardiac and pectoral fin defects due to Tbx5 downregulation and increases the viability of Tbx5 morphants.
The miR-17-92 cluster has been largely studied as oncogene in tumor and, more recently, its role in cardiovascular system has been also highlighted35,36. This cluster plays a role in angiogenesis37 and it is able to induce cardiomyocyte proliferation in post-natal and adult hearts38. While Ventura in 2008 showed that deletion of miR-17-92 in mice causes ventricular septal defects, Danielson et al., in 2013 observed that overexpression of this cluster in cardiac and smooth muscle tissues induces dilated, hypertrophic cardiomyopathy and arrhythmia27,39. These data highlight the importance of this cluster in regulating cardiac development. Moreover, very recently, Han et al.40 reported also forelimb defects in miR-17 ~ 92 deleted mice. More specifically, limb and digit malformations are some of the consequences of monoallelic microdeletions involving the miR-17 ~ 92 cluster in a subset of individuals with Feingold syndrome40,41.
Our data show that, although Tbx5 is able to modulate the miR-17-92 cluster, only miR-19a is effective in rescuing cardiac and fin defects of Tbx5a morphants. Also mir-19a is the only member of the miR-17-92 cluster which resulted significantly decreased in the NGS analysis by Tbx5 depletion. This difference among miRNAs of the same cluster might be due to the extensive post-transcriptional regulation which characterizes miRNA maturation42,43.
In accordance with a cardiac role of the miR-17-92 cluster, we showed that dysregulation of miR-19a levels alters heart development. Overexpression of miR-19a induces defects of dose-dependent severity ranging from looping defects to cardia bifida (F 4A,B). Recently, overexpression of miR-19b has been shown to impact left-right symmetry and cardiac development of zebrafish embryos; inhibition of the Wnt signaling pathway by miR-19b direct ctnnb1 targeting has been indicated as its possible mechanism44. However, in our data the expression of ctnnb1 results unchanged in Tbx5a morphants and it is not decreased by co-injection of miR-19a modulation.
Downregulation of miR-19a by morpholino microinjection was ineffective even using very high doses (10 ng) of MO-19a. In line with this results, Han et al., characterizing an allelic series of genetically engineered mice harboring selective targeted deletions of individual components of the miR-17 ~ 92 cluster, showed that the cardiac defects observed in the miR-17~92–null mice27 were only detected upon deletion of the entire cluster40. A minimal effect of miRNA-mediated loss of function is frequently observed in experimental approaches45,46,47. An explanation for this phenomenon might be the existence of compensatory mechanisms which re-balance a regulatory network when the expression of a single component is slightly altered47. However, a general observation is that the miRNA effect can become evident in conditions of stress or injury which causes a strong unbalance48,49. Our experiments performed with sub-phenotypic doses of MO-Tbx5a (Fig. 4C,D) are in line with these data and support the hypothesis of synergism between miR-19a and Tbx5a in zebrafish.
At genome-wide level, we showed that miR-19a injection is able to rescue the global gene expression profile of Tbx5 morphants while microarray data clearly demonstrate that more than a half of the genes altered by Tbx5a depletion are affected by miR19a. Furthermore, the majority of transcripts significantly upregulated in MO-Tbx5a vs. WT embryos are significantly downregulated in MO-Tbx5a + miR-19a vs. Mo-Tbx5a (Fig. 6C, IIQ) and viceversa (Fig. 6C, IVQ). The remarkable impact that miR-19a has even at the global gene expression level was supported by the observation that putative miR-19a targets are enriched in transcripts upregulated in MO-Tbx5 vs. WT embryos and downregulated by miR-19a co-injection (Fig. 6C, IIQ) compared to the other classes of modulated transcripts.
Among these putative targets MEF2CA, a transcription factor which physically interacts with Tbx5 to synergistically activate gene transcription50, has nine putative miR-19 binding sites, making it the best candidate among miR-19a targets. Increasing MEF2C levels in the presence of a Tbx5 decrease might generate a strong unbalance between these two interacting TFs. It has been demonstrated that the relative levels of crucial cardiac TFs working within complexes can be more important for heart development than the absolute levels of these regulators: disruption of these dosage-sensitive interactions could be one of the mechanistic cause of CHDs51. Besides MEF2CA, also MEF2AA, which is expressed in zebrafish embryonal cardiomyocytes and it is required for cardiac contractility52, is anti-regulated by miR-19. Camk2n1a, an inhibitor of the calcium/calmodulin-dependent protein kinase II(CaMKII), might be also a strong candidate target. CaMKII is necessary for proper heart and fin development and its expression has been shown to be dependent on Tbx5 activity53. More specifically, Tbx5 might affect CaMKII expression by acting on its inhibitor through miR-19a modulation. Indeed, dual luciferase assays performed with reporter plasmids carrying the cloned sequences of the MEF2CA-and Camk2n1a-3’UTR support the miR-19a direct control (Fig. S7B). We also identified several potassium and sodium channel forming proteins such as SCN8aa, cacna1ab and kctd8, kctd12.2, kctd15b, this observation is in line with the important role played by Tbx5 in cardiac contractility54,55. Moreover, the selection of putative miR-19a targets includes also a number of chromatin remodeling proteins (Smarca2, Smarcc1a, Hmga1b, DNMT4, Kdm5ba and Wdr5).
As a whole,these results indicate the complexity of miR-19a functions and its crucial role in the Tbx5 regulatory circuit. Besides providing a tool for identifying new possible targets for HOS, our study in principle shows that modulating miR-19a can positively impact cardiac defects associated with a reduced dosage of Tbx5.
Materials and Methods
More details can be found in SI Materials and Methods
Wild-type AB, Tg(flk1:EGFP), Tg(Myl7:EGFP) and Tg(Tie2:GFP) lines were used in these studies. Zebrafish were raised and maintained under standard laboratory conditions (Westerfileld M zebrafish book) in Zebrafish Housing Systems (Tecniplast, Varese, Italy).
The zebrafish facility, where all the experiments have been performed, is part of the CENTRO di BIOMEDICINA SPERIMENTALE (CBS) of the Area della Ricerca del CNR, Via Moruzzi 1, 56124 Pisa. The zebrafish facility has been authorized by the Italian Ministry of Health with the authorization n°297/2012-A of the 12/21/2012.
The corresponding author declares that all the methods were carried out in accordance with the approved guidelines and that all experimental protocols were approved by the Italian Ministry of Health. Moreover all the technitians and researcher who take care of the animals and perform the experiments are appropriately trained by attending specific courses.
One-cell stage embryos were injected with a constant injection volume (1 nl, confirmed by volume analysis) using a microinjector (Tritech Research, Los Angeles CA USA). The miRNA mimics used are listed in Table S2.
MO-Tbx5a and MO-Tbx5b (Gene Tools) were already described in18. The morpholino targeting miR-19a and MO-Ct are the following: MO-miR-19a, CATCAGTTTTG CATAGATTTGCACA; MO-Ct, CCTCTTACCTCAGTTACAATTTATA.
How to cite this article: Chiavacci, E. et al. MicroRNA 19a replacement partially rescues fin and cardiac defects in zebrafish model of Holt Oram syndrome. Sci. Rep. 5, 18240; doi: 10.1038/srep18240 (2015).
Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233, doi: 10.1016/j.cell.2009.01.002 (2009).
Thomas, M., Lieberman, J. & Lal, A. Desperately seeking microRNA targets. Nature structural & molecular biology 17, 1169–1174, doi: 10.1038/nsmb.1921 (2010).
Trajkovski, M. et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474, 649–653, doi: 10.1038/nature10112 (2011).
Martins, M. et al. Convergence of miRNA expression profiling, alpha-synuclein interacton and GWAS in Parkinson’s disease. PLoS One 6, e25443, doi: 10.1371/journal.pone.0025443 (2011).
Kim, J. et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220–1224, doi: 10.1126/science.1140481 (2007).
Calin, G. A. et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99, 15524–15529, doi: 10.1073/pnas.242606799 (2002).
Lu, M. et al. An analysis of human microRNA and disease associations. PLoS One 3, e3420, doi: 10.1371/journal.pone.0003420 (2008).
van Rooij, E. & Olson, E. N. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117, 2369–2376, doi: 10.1172/JCI33099 (2007).
Thum, T., Catalucci, D. & Bauersachs, J. MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc Res 79, 562–570, doi: 10.1093/cvr/cvn137 (2008).
Divakaran, V. & Mann, D. L. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res 103, 1072–1083, doi: 10.1161/CIRCRESAHA.108.183087 (2008).
Rayner, K. J. et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570–1573, doi: 10.1126/science.1189862 (2010).
Cordes, K. R. et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460, 705–710, doi: 10.1038/nature08195 (2009).
Basson, C. T. et al. The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med 330, 885–891 (1994).
Basson, C. T. et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 15, 30–35, doi: 10.1038/ng0197-30 (1997).
Basson, C. T. et al. Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci USA 96, 2919–2924 (1999).
Bruneau, B. G. et al. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106, 709–721 (2001).
Mori, A. D. et al. Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis. Dev Biol 297, 566–586 (2006).
Chiavacci, E. et al. MicroRNA 218 mediates the effects of Tbx5a over-expression on zebrafish heart development. PLoS One 7, e50536, doi: 10.1371/journal.pone.0050536 (2012).
Albalat, R., Baquero, M. & Minguillon, C. Identification and characterisation of the developmental expression pattern of tbx5b, a novel tbx5 gene in zebrafish. Gene Expr Patterns 10, 24–30 (2010).
Parrie, L. E., Renfrew, E. M., Wal, A. V., Mueller, R. L. & Garrity, D. M. Zebrafish tbx5 paralogs demonstrate independent essential requirements in cardiac and pectoral fin development. Dev Dyn 242, 475–492, doi: 10.1002/dvdy.23953 (2013).
Ahn, D. G., Kourakis, M. J., Rohde, L. A., Silver, L. M. & Ho, R. K. T-box gene tbx5 is essential for formation of the pectoral limb bud. Nature 417, 754–758 (2002).
Chiavacci, E. et al. The zebrafish/tumor xenograft angiogenesis assay as a tool for screening anti-angiogenic miRNAs. Cytotechnology, doi: 10.1007/s10616-014-9735-y (2014).
Garrity, D. M., Childs, S. & Fishman, M. C. The heartstrings mutation in zebrafish causes heart/fin Tbx5 deficiency syndrome. Development 129, 4635–4645 (2002).
Habara-Ohkubo, A. Differentiation of beating cardiac muscle cells from a derivative of P19 embryonal carcinoma cells. Cell Struct Funct 21, 101–110 (1996).
Snyder, M., Huang, X. Y. & Zhang, J. J. Stat3 directly controls the expression of Tbx5, Nkx2.5 and GATA4 and is essential for cardiomyocyte differentiation of P19CL6 cells. J Biol Chem 285, 23639–23646 (2010).
Claycomb, W. C. et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 95, 2979–2984 (1998).
Ventura, A. et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132, 875–886, doi: 10.1016/j.cell.2008.02.019 (2008).
Pickert, L., Reuter, I., Klawonn, F. & Wingender, E. Transcription regulatory region analysis using signal detection and fuzzy clustering. Bioinformatics 14, 244–251 (1998).
Camarata, T. et al. Pdlim7 (LMP4) regulation of Tbx5 specifies zebrafish heart atrio-ventricular boundary and valve formation. Dev Biol 337, 233–245, doi: 10.1016/j.ydbio.2009.10.039 (2010).
Walsh, E. C. & Stainier, D. Y. UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish. Science 293, 1670–1673, doi: 10.1126/science.293.5535.1670 (2001).
Martinez-Barbera, J. P., Toresson, H., Da Rocha, S. & Krauss, S. Cloning and expression of three members of the zebrafish Bmp family: Bmp2a, Bmp2b and Bmp4. Gene 198, 53–59 (1997).
Liu, J. & Stainier, D. Y. Tbx5 and Bmp signaling are essential for proepicardium specification in zebrafish. Circ Res 106, 1818–1828, doi: 10.1161/CIRCRESAHA.110.217950 (2010).
Kerr, M. K. & Churchill, G. A. Bootstrapping cluster analysis: assessing the reliability of conclusions from microarray experiments. Proc Natl Acad Sci USA 98, 8961–8965, doi: 10.1073/pnas.161273698 (2001).
Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25, 25–29, doi: 10.1038/75556 (2000).
Chen, J. et al. mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ Res 112, 1557–1566, doi: 10.1161/CIRCRESAHA.112.300658 (2013).
Zhou, M., Cai, J., Tang, Y. & Zhao, Q. MiR-17-92 cluster is a novel regulatory gene of cardiac ischemic/reperfusion injury. Medical hypotheses 81, 108–110, doi: 10.1016/j.mehy.2013.03.043 (2013).
Doebele, C. et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 115, 4944–4950, doi: 10.1182/blood-2010-01-264812 (2010).
Chen, J. & Chien, K. R. Complexity in simplicity: monogenic disorders and complex cardiomyopathies. J Clin Invest 103, 1483–1485, doi: 10.1172/JCI7297 (1999).
Danielson, L. S. et al. Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 27, 1460–1467, doi: 10.1096/fj.12-221994 (2013).
Han, Y. C. et al. An allelic series of miR-17 approximately 92-mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron. Nat Genet, doi: 10.1038/ng.3321 (2015).
de Pontual, L. et al. Germline deletion of the miR-17 approximately 92 cluster causes skeletal and growth defects in humans. Nat Genet 43, 1026–1030, doi: 10.1038/ng.915 (2011).
Thomson, J. M. et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20, 2202–2207, doi: 10.1101/gad.1444406 (2006).
Winter, J., Jung, S., Keller, S., Gregory, R. I. & Diederichs, S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nature cell biology 11, 228–234, doi: 10.1038/ncb0309-228 (2009).
Li, M. et al. Overexpression of miR-19b impairs cardiac development in zebrafish by targeting ctnnb1. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry and pharmacology 33, 1988–2002, doi: 10.1159/000362975 (2014).
Miska, E. A. et al. Most Caenorhabditis elegans microRNAs are individually not essential for development or viability. PLoS Genet 3, e215, doi: 10.1371/journal.pgen.0030215 (2007).
Park, C. Y., Choi, Y. S. & McManus, M. T. Analysis of microRNA knockouts in mice. Hum Mol Genet 19, R169–175, doi: 10.1093/hmg/ddq367 (2010).
van Rooij, E. & Olson, E. N. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nature reviews. Drug discovery 11, 860–872, doi: 10.1038/nrd3864 (2012).
Small, E. M., Frost, R. J. & Olson, E. N. MicroRNAs add a new dimension to cardiovascular disease. Circulation 121, 1022–1032, doi: 10.1161/CIRCULATIONAHA.109.889048 (2010).
Leung, A. K. & Sharp, P. A. MicroRNA functions in stress responses. Mol Cell 40, 205–215, doi: 10.1016/j.molcel.2010.09.027 (2010).
Ghosh, T. K. et al. Physical interaction between TBX5 and MEF2C is required for early heart development. Molecular and cellular biology 29, 2205–2218, doi: 10.1128/MCB.01923-08 (2009).
Takeuchi, J. K. et al. Chromatin remodelling complex dosage modulates transcription factor function in heart development. Nat Commun 2, 187, doi: 10.1038/ncomms1187 (2011).
Wang, Y. X. et al. Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility. Cardiovasc Res 74, 290–303, doi: 10.1016/j.cardiores.2007.02.007 (2007).
Rothschild, S. C. et al. Tbx5-mediated expression of Ca(2+)/calmodulin-dependent protein kinase II is necessary for zebrafish cardiac and pectoral fin morphogenesis. Dev Biol 330, 175–184, doi: 10.1016/j.ydbio.2009.03.024 (2009).
van den Boogaard, M. et al. Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer. J Clin Invest 122, 2519–2530, doi: 10.1172/JCI62613 (2012).
Zhu, Y. et al. Tbx5-dependent pathway regulating diastolic function in congenital heart disease. Proc Natl Acad Sci USA 105, 5519–5524, doi: 10.1073/pnas.0801779105 (2008).
Shimodaira, H. & Hasegawa, M. CONSEL: for assessing the confidence of phylogenetic tree selection. Bioinformatics 17, 1246–1247 (2001).
We thank Dr. A. Baldini (Telethon Institute of Genetics and Medicine, Napoli, Italy) for kindly providing the P19CL6 cells, Prof. W.C. Claycomb (LSU Health Sciences Center New Orleans, LA 70112) for kindly providing HL1 cells, Dr. R. Ripa (Scuola Normale Superiore, Pisa, Italy) for miR-17-92 cluster riboprobe generation and Monica Evangelista for experimental and technical assistance. The present work is partially supported by the Flagship project InterOmics (PB. P05), funded by the Italian Ministry for Instruction University and Research (MIUR) and CNR organizations and by the joint IIT-IFC Laboratory of Integrative Systems Medicine (LISM).
The authors declare no competing financial interests.
Electronic supplementary material
About this article
Cite this article
Chiavacci, E., D’Aurizio, R., Guzzolino, E. et al. MicroRNA 19a replacement partially rescues fin and cardiac defects in zebrafish model of Holt Oram syndrome. Sci Rep 5, 18240 (2015) doi:10.1038/srep18240
miR-182-5p is an evolutionarily conserved Tbx5 effector that impacts cardiac development and electrical activity in zebrafish
Cellular and Molecular Life Sciences (2019)
The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular disease
International Journal of Cardiology (2019)
Post-transcriptional Modulation of Sphingosine-1-Phosphate Receptor 1 by miR-19a Affects Cardiovascular Development in Zebrafish
Frontiers in Cell and Developmental Biology (2018)
Journal of Cardiovascular Development and Disease (2018)
Early frameshift alleles of zebrafish <em>tbx5a</em> that fail to develop the heartstrings phenotype